ACOR - Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q4 2018 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q4 2018 Results Conference Call
February 14, 2019 4:30 PM ET
Company Participants
Felicia Vonella — Executive Director-Investor Relations
Ron Cohen — Chief Executive Officer
Conference Call Participants
Cory Kasimov — JP Morgan
Ben Burnett — Stifel
Paul Matteis — Stifel
Sadia Rahman — Cantor Fitzgerald
Phil Nadeau — Cowen and Company
Michael Yee — Jefferies
Salveen Richter — Goldman Sachs
Silvan Tuerkcan — Oppenheimer
Edward Marks — HC Wainwright
Presentation
Operator
Welcome to the Acorda Therapeutics Fourth Quarter Year-End 2018 Update. At this time all participants are in a listen-only